Molecular interactions of the IGF system

Khandwala, 2000, The effects of insulin-like growth factors on tumorigenesis and neoplastic growth, Endocr Rev, 21, 215, 10.1210/er.21.3.215 Pollak, 2004, Insulin-like growth factors and neoplasia, Nat Rev Cancer, 4, 505, 10.1038/nrc1387 Baumann, 2002, Genetic characterization of growth hormone deficiency and resistance: implications for treatment with recombinant growth hormone, Am J Pharmacogenomics, 2, 93, 10.2165/00129785-200202020-00003 Laron, 2004, Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience, J Clin Endocrinol Metab, 89, 1031, 10.1210/jc.2003-031033 O’Connor, 2003, Regulation of IGF-I receptor signaling in tumor cells, Horm Metab Res, 35, 771, 10.1055/s-2004-814166 Kim, 2002, Signalling through IGF-I and insulin receptors: where is the specificity?, Growth Horm IGF Res, 12, 84, 10.1054/ghir.2002.0265 Rinderknecht, 1978, The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin, J Biol Chem, 253, 2769, 10.1016/S0021-9258(17)40889-1 Cooke, 1991, Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study, Biochemistry, 30, 5484, 10.1021/bi00236a022 Sato, 1993, Three-dimensional structure of human insulin-like growth factor-I (IGF-I) determined by 1H-NMR and distance geometry, Int J Pept Protein Res, 41, 433, 10.1111/j.1399-3011.1993.tb00462.x Schaffer, 2003, Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I, Biochemistry, 42, 9324, 10.1021/bi034386c Vajdos, 2001, Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions, Biochemistry, 40, 11022, 10.1021/bi0109111 Zeslawski, 2001, The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5, EMBO J, 20, 3638, 10.1093/emboj/20.14.3638 Brzozowski, 2002, Structural origins of the functional divergence of human insulin-like growth factor-I and insulin, Biochemistry, 41, 9389, 10.1021/bi020084j Siwanowicz, 2005, Structural basis for the regulation of insulin-like growth factors by IGF binding proteins, Structure, 13, 155, 10.1016/j.str.2004.11.009 Terasawa, 1994, Solution structure of human insulin-like growth factor II; recognition sites for receptors and binding proteins, EMBO J, 13, 5590, 10.1002/j.1460-2075.1994.tb06896.x Torres, 1995, Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions, J Mol Biol, 248, 385, 10.1016/S0022-2836(95)80058-1 Bentley, 1976, Structure of insulin in 4-zinc insulin, Nature, 261, 166, 10.1038/261166a0 Baker, 1988, The structure of 2Zn pig insulin crystals at 1.5 A resolution, Philos Trans R Soc Lond B Biol Sci, 319, 369, 10.1098/rstb.1988.0058 Weiss, 1990, NMR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition, Biochemistry, 29, 8389, 10.1021/bi00488a028 Walenkamp, 2005, Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation, J Clin Endocrinol Metab, 90, 2855, 10.1210/jc.2004-1254 Denley, 2005, Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development, Mol Endocrinol, 19, 711, 10.1210/me.2004-0409 Woods, 1997, Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature, Acta Paediatr Suppl, 423, 39, 10.1111/j.1651-2227.1997.tb18367.x Liu, 1993, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r), Cell, 75, 59 DeChiara, 1990, A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting, Nature, 345, 78, 10.1038/345078a0 Pandini, 2003, Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A, J Biol Chem, 278, 42178, 10.1074/jbc.M304980200 Pandini, 2004, Igf-ii binding to insulin receptor isoform a induces a partially different gene expression profile from insulin binding, Ann NY Acad Sci, 450, 10.1196/annals.1322.053 Nakae, 2001, Distinct and overlapping functions of insulin and IGF-I receptors, Endocr Rev, 22, 818, 10.1210/er.22.6.818 Denley, 2003, The insulin receptor isoform exon 11− (IR-A) in cancer and other diseases: a review, Horm Metab Res, 35, 778, 10.1055/s-2004-814157 Sesti, 2000, Insulin receptor variant forms and type 2 diabetes mellitus, Pharmacogenomics, 1, 49, 10.1517/14622416.1.1.49 Pandini, 1999, Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling, Clin Cancer Res, 5, 1935 Adams, 2000, Structure and function of the type 1 insulin-like growth factor receptor, Cell Mol Life Sci, 57, 1050, 10.1007/PL00000744 Czech, 1982, Structural and functional homologies in the receptors for insulin and the insulin-like growth factors, Cell, 31, 8, 10.1016/0092-8674(82)90399-3 Bhaumick, 1981, Somatomedin receptor of human placenta: solubilization, photolabeling, partial purification, and comparison with insulin receptor, Proc Natl Acad Sci USA, 78, 4279, 10.1073/pnas.78.7.4279 Chernausek, 1981, Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labeling, Biochemistry, 20, 7345, 10.1021/bi00529a004 Siddle, 2001, Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors, Biochem Soc Trans, 29, 513, 10.1042/bst0290513 De Meyts, 2002, Structural biology of insulin and IGF1 receptors: implications for drug design, Nat Rev Drug Discov, 1, 769, 10.1038/nrd917 Schaefer, 1990, Deletion analysis of the human insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomeric alpha-subunit, J Biol Chem, 265, 13248, 10.1016/S0021-9258(19)38291-2 Brandt, 2001, Dimeric fragment of the insulin receptor alpha-subunit binds insulin with full holoreceptor affinity, J Biol Chem, 276, 12378, 10.1074/jbc.M009402200 Kasuga, 1982, Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor, Science, 215, 185, 10.1126/science.7031900 Rubin, 1983, Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I, Nature, 305, 438, 10.1038/305438a0 Garrett, 1998, Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor, Nature, 394, 395, 10.1038/28668 Schumacher, 1991, Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors, J Biol Chem, 266, 19288, 10.1016/S0021-9258(18)54996-6 Whittaker, 2001, Alanine scanning mutagenesis of a type 1 insulin-like growth factor receptor ligand binding site, J Biol Chem, 276, 43980, 10.1074/jbc.M102863200 Sorensen, 2004, Mapping of the insulin-like growth factor II binding site of the Type I insulin-like growth factor receptor by alanine scanning mutagenesis, FEBS Lett, 565, 19, 10.1016/j.febslet.2004.03.077 Andersen, 1990, Changing the insulin receptor to possess insulin-like growth factor I ligand specificity, Biochemistry, 29, 7363, 10.1021/bi00484a002 Kjeldsen, 1991, The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site, Proc Natl Acad Sci USA, 88, 4404, 10.1073/pnas.88.10.4404 Wedekind, 1989, Hormone binding site of the insulin receptor: analysis using photoaffinity-mediated avidin complexing, Biol Chem Hoppe Seyler, 370, 251, 10.1515/bchm3.1989.370.1.251 Fabry, 1992, Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin, J Biol Chem, 267, 8950, 10.1016/S0021-9258(19)50372-6 Kurose, 1994, Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor, J Biol Chem, 269, 29190, 10.1016/S0021-9258(19)62029-6 Williams, 1995, Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis, J Biol Chem, 270, 3012, 10.1074/jbc.270.7.3012 Mynarcik, 1996, Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha subunit, J Biol Chem, 271, 2439, 10.1074/jbc.271.5.2439 Whittaker, 2002, Comparison of the functional insulin binding epitopes of the A and B isoforms of the insulin receptor, J Biol Chem, 277, 47380, 10.1074/jbc.M208371200 Firth, 2002, Cellular actions of the insulin-like growth factor binding proteins, Endocr Rev, 23, 824, 10.1210/er.2001-0033 Clemmons, 2001, Use of mutagenesis to probe IGF-binding protein structure/function relationships, Endocr Rev, 22, 800, 10.1210/er.22.6.800 Frystyk, 2004, Free insulin-like growth factors – measurements and relationships to growth hormone secretion and glucose homeostasis, Growth Horm IGF Res, 14, 337, 10.1016/j.ghir.2004.06.001 Baxter, 2000, Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities, Am J Physiol Endocrinol Metab, 278, E967, 10.1152/ajpendo.2000.278.6.E967 Hwa, 1999, The insulin-like growth factor-binding protein (IGFBP) superfamily, Endocr Rev, 20, 761, 10.1210/er.20.6.761 Carrick, 2001, The interaction of insulin-like growth factors (IGFs) with insulin-like growth factor binding proteins (IGFBPs): a review, Lett Pept Sci, 8, 147, 10.1007/BF02446511 Headey, 2004, C-terminal domain of insulin-like growth factor binding protein-6: structure and interaction with insulin-like growth factor-II, Mol Endocrinol, 10.1210/me.2004-0248 Headey, 2004, Binding site for the C-domain of insulin-like growth factor (IGF) binding protein-6 on IGF-II; implications for inhibition of IGF actions, FEBS Lett, 568, 19, 10.1016/j.febslet.2004.04.091 Scott, 2004, The role of the M6P/IGF-II receptor in cancer: tumor suppression or garbage disposal?, Horm Metab Res, 36, 261, 10.1055/s-2004-814477 De Souza, 1995, M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity, Nat Genet, 11, 447, 10.1038/ng1295-447 Oka, 2002, M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan, Hepatology, 35, 1153, 10.1053/jhep.2002.32669 Jamieson, 2003, M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis, BMC Cancer, 3, 4, 10.1186/1471-2407-3-4 Lee, 1986, Identification of receptors for insulin-like growth factor II in two insulin-like growth factor II producing cell lines, Biochem Biophys Res Commun, 134, 595, 10.1016/S0006-291X(86)80461-2 Ewton, 1987, The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor, Endocrinology, 120, 115, 10.1210/endo-120-1-115 Tong, 1988, The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II, J Biol Chem, 263, 2585, 10.1016/S0021-9258(18)69105-7 Morgan, 1987, Insulin-like growth factor II receptor as a multifunctional binding protein, Nature, 329, 301, 10.1038/329301a0 Oshima, 1988, The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in COS cells, J Biol Chem, 263, 2553, 10.1016/S0021-9258(18)69243-9 Kornfeld, 1992, Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors, Annu Rev Biochem, 61, 307, 10.1146/annurev.bi.61.070192.001515 Devi, 1998, An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor, Mol Endocrinol, 12, 1661, 10.1210/me.12.11.1661 Tong, 1989, Ligand interactions of the cation-independent mannose 6-phosphate receptor. The stoichiometry of mannose 6-phosphate binding, J Biol Chem, 264, 7962, 10.1016/S0021-9258(18)83136-2 Westlund, 1991, The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of mannose 6-phosphate binding sites to domains 1–3 and 7–11 of the extracytoplasmic region, J Biol Chem, 266, 23233, 10.1016/S0021-9258(18)54487-2 Brown, 2002, Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur, EMBO J, 21, 1054, 10.1093/emboj/21.5.1054 Garmroudi, 1994, Localization of the insulin-like growth factor II (IGF-II) binding/cross-linking site of the IGF-II/mannose 6-phosphate receptor to extracellular repeats 10–11, J Biol Chem, 269, 26944, 10.1016/S0021-9258(18)47110-4 Bayne, 1988, Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor, J Biol Chem, 263, 6233, 10.1016/S0021-9258(18)68777-0 Shooter, 1996, Insulin-like growth factor (IGF)-I A- and B-domain analogues with altered type 1 IGF and insulin receptor binding specificities, J Mol Endocrinol, 17, 237, 10.1677/jme.0.0170237 Hodgson, 1995, Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor, Eur J Biochem, 233, 299, 10.1111/j.1432-1033.1995.299_1.x Cascieri, 1988, Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor, Biochemistry, 27, 3229, 10.1021/bi00409a016 Bayne, 1990, The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor, J Biol Chem, 265, 15648, 10.1016/S0021-9258(18)55447-8 Magee, 1999, Insulin-like growth factor I and its binding proteins: a study of the binding interface using B-domain analogues, Biochemistry, 38, 15863, 10.1021/bi9910070 Jansson, 1998, The insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis, J Biol Chem, 273, 24701, 10.1074/jbc.273.38.24701 Jansson, 1997, Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor, Biochemistry, 36, 4108, 10.1021/bi961553i Sakano, 1991, The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor, J Biol Chem, 266, 20626, 10.1016/S0021-9258(18)54755-4 Roth, 1991, Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62–67, Biochem Biophys Res Commun, 181, 907, 10.1016/0006-291X(91)91277-J Hashimoto, 1995, N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions, J Biol Chem, 270, 18013, 10.1074/jbc.270.30.18013 Bagley, 1989, A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide, Biochem J, 259, 665, 10.1042/bj2590665 Cara, 1990, An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranes, J Biol Chem, 265, 17820, 10.1016/S0021-9258(18)38237-1 Bayne, 1989, The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor, J Biol Chem, 264, 11004, 10.1016/S0021-9258(18)60418-1 Gill, 1996, Engineering the C-region of human insulin-like growth factor-1: implications for receptor binding, Protein Eng, 9, 1011, 10.1093/protein/9.11.1011 De Wolf, 1996, Solution structure of a mini IGF-1, Protein Sci, 5, 2193, 10.1002/pro.5560051106 Zhang, 1994, Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity, J Biol Chem, 269, 10609, 10.1016/S0021-9258(17)34103-0 Denley, 2004, Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR, Mol Endocrinol, 18, 2502, 10.1210/me.2004-0183 Kobayashi, 1986, Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin, Biochem Biophys Res Commun, 137, 250, 10.1016/0006-291X(86)91203-9 Nanjo, 1987, Insulin Wakayama: familial mutant insulin syndrome in Japan, Diabetologia, 30, 87, 10.1007/BF00274577 Xu, 2004, Diabetes-associated mutations in insulin identify invariant receptor contacts, Diabetes, 53, 1599, 10.2337/diabetes.53.6.1599 Hua, 1991, Receptor binding redefined by a structural switch in a mutant human insulin, Nature, 354, 238, 10.1038/354238a0 Cascieri, 1989, Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors, J Biol Chem, 264, 2199, 10.1016/S0021-9258(18)94162-1 Forbes, 2001, Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificity, Growth Factors, 19, 163, 10.3109/08977190109001084 Schaffer, 1994, A model for insulin binding to the insulin receptor, Eur J Biochem, 221, 1127, 10.1111/j.1432-1033.1994.tb18833.x De Meyts, 1994, The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling, Diabetologia, 37, S135, 10.1007/BF00400837 De Meyts, 2004, Insulin and its receptor: structure, function and evolution, Bioessays, 26, 1351, 10.1002/bies.20151 Xu, 2004, Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor(,), Biochemistry, 43, 8356, 10.1021/bi0497796 Wan, 2004, Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues, Biochemistry, 43, 16119, 10.1021/bi048223f Huang, 2004, How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor, J Mol Biol, 341, 529, 10.1016/j.jmb.2004.05.023 Hodgson, 1996, Involvement of phenylalanine 23 in the binding of IGF-1 to the insulin and type I IGF receptor, Regul Pept, 66, 191, 10.1016/S0167-0115(96)00102-4 Kristensen, 1995, A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor, Biochem J, 305, 981, 10.1042/bj3050981 Sato, 1992, 1H-NMR assignment and secondary structure of human insulin-like growth factor-I (IGF-I) in solution, J Biochem (Tokyo), 111, 529, 10.1093/oxfordjournals.jbchem.a123791 Laajoki L, Milner S, Francis G, Carver J, Keniry M. BioMagResBank (http://www.bmrb.wisc.edu/) entry number 4278; 1998. Dubaquie, 2001, Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance, Endocrinology, 142, 165, 10.1210/en.142.1.165 Dubaquie, 1999, Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3, Biochemistry, 38, 6386, 10.1021/bi990089p Clemmons, 1992, Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs, Endocrinology, 131, 890, 10.1210/en.131.2.890 Bach, 1993, Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1–6, J Biol Chem, 268, 9246, 10.1016/S0021-9258(18)98342-0 Clemmons, 1990, Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity, J Biol Chem, 265, 12210, 10.1016/S0021-9258(19)38332-2 Moss, 1991, Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction, J Biol Chem, 266, 909, 10.1016/S0021-9258(17)35259-6 Kalus, 1998, Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions, EMBO J, 17, 6558, 10.1093/emboj/17.22.6558 Carrick FE, Hinds MG, McNeil KA, Wallace JC, Forbes BE, Norton RS. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance. J Mol Endocrinol, in press. Oh, 1993, Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1–4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs, Endocrinol, 132, 1337, 10.1210/en.132.3.1337 Burgisser, 1991, Mutants of human insulin-like growth factor II with altered affinities for the type 1 and type 2 insulin-like growth factor receptor, J Biol Chem, 266, 1029, 10.1016/S0021-9258(17)35278-X Yandell, 1999, Kangaroo IGF-II is structurally and functionally similar to the human, J Endocrinol, 161, 445, 10.1677/joe.0.1610445 Blundell, 1978, Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding, Proc Natl Acad Sci USA, 75, 180, 10.1073/pnas.75.1.180 Pandini, 2002, Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved, J Biol Chem, 277, 39684, 10.1074/jbc.M202766200 King, 1992, Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu3, following their expression in Escherichia coli as fusion proteins, J Mol Endocrinol, 8, 29, 10.1677/jme.0.0080029 Francis, 1992, Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency, J Mol Endocrinol, 8, 213, 10.1677/jme.0.0080213